Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Novartis Ag (NVSEF) Non Operating Income (2016 - 2024)

Historic Non Operating Income for Novartis Ag (NVSEF) over the last 11 years, with Q1 2024 value amounting to $215.0 million.

  • Novartis Ag's Non Operating Income rose 12395.83% to $215.0 million in Q1 2024 from the same period last year, while for Mar 2024 it was $215.0 million, marking a year-over-year increase of 12395.83%. This contributed to the annual value of $1.2 billion for FY2016, which is 405.77% up from last year.
  • As of Q1 2024, Novartis Ag's Non Operating Income stood at $215.0 million, which was up 12395.83% from $96.0 million recorded in Q1 2023.
  • In the past 5 years, Novartis Ag's Non Operating Income registered a high of $215.0 million during Q1 2024, and its lowest value of $96.0 million during Q1 2023.